RCE 2.06% 49.5¢ recce pharmaceuticals ltd

Ann: Ethics Approval to Start Phase 1 Intravenous Clinical Trial, page-29

  1. 4,020 Posts.
    lightbulb Created with Sketch. 473
    yes with the iv first in human trials starting tomorrow and the time frame for data flow of results so quick, i think we maybbe right on the cusp of a breakout here
    the burns trial data should be available soon and application to new patients there ongoing- but as we know the results have been spectacular!
    the combination of the burns trial success and the absence of toxicity from the iv trials should really launch this stock
    i cant wait very exciting
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
49.5¢
Change
0.010(2.06%)
Mkt cap ! $114.6M
Open High Low Value Volume
48.5¢ 51.0¢ 48.5¢ $1.909K 3.908K

Buyers (Bids)

No. Vol. Price($)
4 15775 48.5¢
 

Sellers (Offers)

Price($) Vol. No.
49.5¢ 66869 2
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.